By targeting the BCL6 corepressor such as BCORL1, the migration and invasion of hepatocellular carcinoma (HCC) cells are restrained by miR-876-5p, which provides a new idea for the treatment of HCC [16]. Here, BCOR is linked to hepatocellular carcinoma.